Back to News
AI
The Artificial Intelligence Market in Biopharmaceuticals is Expected to Grow at an Annual Rate of 33.1% as AI Transforms Drug Discovery
Google News AI — Japan·August 6, 2026·1 min read
AI Summary
The biopharmaceutical sector is poised for significant growth in its artificial intelligence market, with an expected average annual growth rate of 33.1%. This growth is attributed to the transformative impact of AI on drug discovery processes.
This story was originally published in another language — the summary above is an English translation. Read the full article at the source.
View original at Google News AI — JapanKeep reading
Wall Street: Google DeepMind's reorganization penalizes Alphabet's stocklerevenu.com · 1h agoThe video is generated by artificial intelligence and does not document military convoys heading towards the Syrian-Iraqi borderverify-sy.com · 1h agoConfidence the key to our artificial intelligence future - Trending Now Sustainable Constructionsustainableconstruction-now.com · 1h agoOpenAI developer warns the "tireless eagle eyes of a million models" are coming for your exposed API keys and crypto walletsThe Decoder · 1h ago
Was this useful?